MAETZOLD DEREK J sold CSTL
September 11, 2026 · Form 4 insider transaction
MAETZOLD DEREK J sold 83 shares of Castle Biosciences, Inc. at $32.78 per share, a transaction worth $2.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
83
Price
$32.78
Total value
$2.7K
InsiderMAETZOLD DEREK J
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 11, 2026
Filing dateSeptember 15, 2026
Shares owned after14,434
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 2, 2026.; Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.